Harmonyx Places Power In Patients With New Payment Model And Website

MEMPHIS, TN--(Marketwired - January 13, 2015) -

Highlighted Links

Harmonyx

Harmonyx, the leading company in affordable and accessible genetic testing, is aiming to change the way medicine is prescribed in America, with patients at the forefront. Harmonyx has left the insurance game and has implemented a progressive patient payment model, opening the door to anyone seeking personal guidance for their prescriptions. With this unique approach in its dedication to patients, Harmonyx is seeking to disrupt industry norms with a new focus on personalized medicine.

Pharmacogenetic testing examines genetic differences to interpret how a drug will metabolize and respond in various people. It is a quickly growing industry that is often misconceived as an expensive luxury. Harmonyx is attempting to change this notion through attainable testing that patients can use to determine if their prescribed medication is going to work for them.

For a cost ranging from $50 to $100, patients can take a simple swab test and obtain their personalized genetic testing results in as little as 24 hours once received by the laboratory, which will indicate if a medication will metabolize effectively in their bodies.

"It is our mission to put the patients first," said Bob Bean, President and CEO of Harmonyx. "Understanding your genes and how medications interact with your body can be the difference in successful or ineffective treatment, which is why making genetic testing easy and affordable is at the core of our philosophy."

At the helm of this new approach is the launch of the new Harmonyx website, featuring an easy-to-navigate interface for patients, pharmacists and physicians. A new patient section allows consumers to easily locate a pharmacy that offers Harmonyx tests near them by simply entering their zip code. A revamped portal on the new site gives pharmacists the ability to sign up for the Harmonyx program and gives pharmacists along with the treating physician access to their patients' results. And an expanded physician page offers a wealth of clear, helpful information and educational resources about the company's program.

Harmonyx offers testing for three classes of medication -- Antiplatelets (Plavix® / clopidogrel), Statins (Zocor® / simvastatin) and ADHD. To learn more about Harmonyx, visit http://www.harmonyxdiagnostics.com.

About Harmonyx:
Harmonyx Diagnostics is an innovative Memphis-based company that is changing the way medicine is prescribed in America. Founded in 2009, Harmonyx believes patients should have the power to pay for affordable genetic testing without the hurdles health insurance can cause. Harmonyx uses a fully automated genotyping system to deliver fast, easy and accurate results to qualified healthcare professionals, helping them determine the appropriate medication and dosing for each patient. Harmonyx is CAP accredited and CLIA-certified automated genetic testing laboratory. For more information, visit www.harmonyxdiagnostics.com.